Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi and Spleen Strengthening Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine. Based on TCM principles of supplementing 'Qi' and strengthening the 'Spleen' (Jianpi), the formula is designed to enhance immune function and support systemic recovery. It is primarily investigated as a supportive care intervention for survivors of Stage II–III gastric cancer who have undergone surgery, with the aim of reducing the incidence of SARS-CoV-2 infection and alleviating symptoms associated with long COVID-like syndrome. The formula is typically administered as an oral decoction or granule preparation to improve postoperative resilience and manage chronic fatigue and other recovery-related complications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi and Spleen Strengthening Formula.